Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45
September 19, 2024 16:01 ET
|
Tectonic Therapeutic
TX45 was well-tolerated with no observed immunogenicity, and demonstrated a favorable PK/PD relationship which was used to identify doses for the Phase 2 clinical trial Results to be presented at...
Cytokinetics Announces Upcoming Presentations at the HCMS Scientific Sessions and the HFSA Annual Scientific Meeting
September 19, 2024 16:00 ET
|
Cytokinetics, Incorporated
Analyses of Effects of Aficamten on Key Clinical Outcomes from SEQUOIA-HCM to be Featured in Late Breaking Clinical Trial Presentation at HFSA SOUTH SAN FRANCISCO, Calif., Sept. 19, 2024 (GLOBE...
Oculis and EURETINA Announce the Winner of the Inaugural Ramin Tadayoni Award
September 19, 2024 13:00 ET
|
Oculis Holding AG
ZUG, Switzerland, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, in...
Texas Health Employee Overcomes Massive Stroke, Returns to Family and Career She Loves
September 19, 2024 11:11 ET
|
Texas Health Resources
Fort Worth, Texas, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Needing gas for the lawn mower, Brandy Pullin decided to make a quick trip to the store, less than a mile from her home. She brushed off a...
Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Steve Caffé, MD as Chief Regulatory Officer
September 19, 2024 08:30 ET
|
Disc Medicine Inc
WATERTOWN, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of...
RenovoRx Announces Presentation at Symposium on Clinical Interventional Oncology Highlighting TAMP™ for Targeted Treatment of Locally Advanced Pancreatic Cancer
September 19, 2024 08:30 ET
|
RenovoRx, Inc.
LOS ALTOS, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology...
Eyconis, Inc. Announces Appointment of Dr. Mark J. Bachleda as Chief Executive Officer and Member of the Board of Directors
September 19, 2024 08:00 ET
|
Eyconis, Inc.
REDWOOD CITY, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Eyconis, Inc., a biopharmaceutical company focused on developing novel, best-in-class therapeutics for eye diseases, today announced that...
Humacyte Announces Allowance of U.S. Patent Covering BioVascular Pancreas (BVP™)
September 19, 2024 08:00 ET
|
Humacyte, Inc
- New U.S. patent covers the design and composition of the BVP - - Positive results from ongoing preclinical studies support the potential of the BVP to deliver insulin-producing islets as a...
Cidara Therapeutics Strengthens its Scientific Advisory Board with Infectious Disease Experts
September 19, 2024 08:00 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC)...
EDAP and Avenda Health Launch World’s First AI-Assisted Focal One® Robotic HIFU Procedures
September 19, 2024 08:00 ET
|
EDAP TMS S.A.
First Unfold AI®-Assisted Focal One procedures successfully performed at the UCLA School of MedicineFDA-cleared Unfold AI enables urologists to...